Mechanisms of drug release from advanced drug formulations such as polymeric-based drug-delivery systems and lipid nanoparticles

다국어 초록 (Multilingual Abstract)

Drug release from a polymeric nanocarrier is affected by several factors including the sort of composition (drug, polymer, and excipient), the ratio of composition, physical or chemical interaction between components, and manufacturing methods. Depending on the mechanism of drug release from the vehicles, it can be divided into four categories (diffusion, solvent, chemical interaction, and stimulated release). Recently, lipids have attracted great interest as carriers for water-insoluble drug delivery. Lipidbased drug-delivery systems have received a lot of interest because of their ability to improve solubility and bioavailability of drugs that are poorly soluble in water. The lipid carrier, formulation strategy, and rational drug-delivery system should be selected appropriately for a lipid-based drug-delivery system to be successful. In this review, the general release characteristics and mechanisms of drug from nanocarriers will be discussed.

참고문헌 (Reference)

1 Burkersroda FV, "Why degradable polymers undergo surface erosion or bulk erosion" 23 : 4221-4231, 2002

2 Min KH, "Tumoral acidic pH- responsive MPEG-poly(β-amino ester)polymeric micelles for cancer targeting therapy" 144 : 259-266, 2010

3 Sarpietro MG, "Transfer kinetics from colloidal drug carriers and liposomes to biomembrane models: DSC studies" 3 : 77-88, 2011

4 Folkman J, "The use of silicone rubber as a carrier for prolonged drug therapy" 4 : 139-142, 1964

5 Crank J, "The mathematics of diffusion" Clarendon Press 1975

6 Li W, "The fine-tuning of thermosensitive and degradable polymer micelles for enhancing intracellular uptake and drug release in tumors" 32 : 3832-3844, 2011

7 Maeda H, "The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo" 65 : 71-79, 2013

8 Xu S, "Targeting receptor-mediated endocytotic pathways with nanoparticles:rationale and advances" 65 : 121-138, 2013

9 Middleton JC, "Synthetic biodegradable polymers as orthopedic devices" 21 : 2335-2346, 2000

10 Jain A, "Stimuli-responsive smart liposomes in cancer targeting" 2016

11 Mehnert W, "Solid lipid nanoparticles: production, characterization and applications" 47 : 165-196, 2001

12 Muller RH, "Solid lipid nanoparticles (SLN)for controlled drug delivery—a review of the state of the art" 50 : 161-177, 2000

13 Muller RH, "Soli lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations" 54 : S131-S155, 2002

14 Gursoy RN, "Self-emulsifying drug delivery systems (SMEDDS) for improved oral delivery of lipophilic drugs" 58 : 173-182, 2004

15 Lee SH, "Self-assembled siRNA–PLGA conjugate micelles for gene silencing" 152 : 152-158, 2011

16 Patel PV, "Self emulsifying drug delivery system: a conventional and alternative approach to improve oral bioavailability of lipophilic drugs" 2 : 9344-9375, 2010

17 Bajpai AK, "Responsive polymers in controlled drug delivery" 33 : 1088-1118, 2008

18 Dahan A, "Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs" 129 : 1-10, 2008

19 Wei Y, "Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes" 9 : 3623-3630, 2014

20 Lee WC, "Preparation and degradation behavior of polyanhydrides nanoparticles" 84 : 138-146, 2008

21 Zhuang CY, "Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability" 394 : 179-185, 2010

22 Freiberg S, "Polymer microspheres for controlled drug release" 282 : 1-18, 2004

23 Torchilin VP, "Peptide and protein drug delivery to and into tumors: challenges and solutions" 8 : 259-266, 2003

24 Acharya S, "PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect" 63 : 170-183, 2011

25 Farah N, "Orally administrable composition capable of providing enhanced bioavailability when ingested"

26 Rajput DS, "Novel integrated approach for the strategic delivery of hydrophobic drugs by the use of self emulsifying drug delivery system" 12 (12): 502-517, 2012

27 Aungst BJ, "Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism" 82 : 979-987, 1993

28 Lee PI, "Novel approach to zero-order drug delivery via immobilized nonuniform drug distribution in glass hydrogels" 73 : 1344-1347, 1984

29 Brannon-Peppas L, "Nanoparticle and targeted systems for cancer therapy" 56 : 1649-1659, 2004

30 Siepmann J, "Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC)" 48 : 139-157, 2001

31 Zeng L, "Modeling drug-carrier interaction in the drug release from nanocarriers" 2011

32 Costa P, "Modeling and comparison of dissolution profiles" 13 : 123-133, 2001

33 Fugit KD, "Mechanistic model and analysis of doxorubicin release from liposomal formulations" 217 : 82-91, 2015

34 Korsmeyer RW, "Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air" 72 : 1189-1191, 1983

35 Higuchi T, "Mechanism of sustained-action medication. Theoretical analysis of release of solid drug dispersed in solid matrices" 52 : 1145-1149, 1963

36 Small EF, "Low-frequency ultrasoundinduced transport across non-raft-forming ternary lipid bilayers" 28 : 14364-14372, 2012

37 Schwarz C, "Lipidnanopartikel: herstellung, charakterisierung, arzneistoffinkorporation and freisetzung, sterilization und lyophilisation" Free University of Berlin 1995

38 Fang JY, "Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)" 70 : 633-640, 2008

39 Pouton CW, "Lipid formulations for oral administration of drugs nanoemulsifying, self-emulsifying and self-microemulsifying drug delivery systems" 11 : S93-S98, 2000

40 Dash S, "Kinetic modeling on drug release from controlled drug delivery systems" 67 : 217-223, 2010

41 Kaity S, "Interpenetrating polymer network of locust bean gum-poly (vinyl alcohol) for controlled release drug delivery" 94 : 456-467, 2013

42 Sobko AA, "Induction of lipid flip-flop colicin E1—a hallmark of proteolipidic pore formation in liposome membranes" 75 : 728-733, 2010

43 Peppas NA, "Hydrogels in pharmaceutical formulations" 50 : 27-46, 2000

44 Lin CC, "Hydrogels in controlled release formulations:network design and mathematical modeling" 58 : 1379-1408, 2006

45 Siegel RA, "Fundamentals and applications of controlled release drug delivery. Advances in delivery science and technology" Springer 21-22, 2012

46 Hayashi T, "Formulation study and drug release mechanism of a new theophylline sustained-release preparation" 304 : 91-101, 2005

47 Pouton CW, "Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system" 29 : 278-287, 2006

48 Lu Y, "Folate-mediated delivery of macromolecular anticancer therapeutic agents" 54 : 675-693, 2002

49 Chang C, "Fabrication of thermosensitive PCL-PNIPAAm-PCL triblock copolymeric micelles for drug delivery" 46 : 3048-3057, 2008

50 Abouelmagd SA, "Extracellularly activatable nanocarriers for drug delivery to tumors" 11 : 1601-1618, 2014

51 Mahesh D, "Emulsion based drug delivery system" 3 : 2-8, 2001

52 Fugit KD, "Dynamic, nonsink method for the simultaneous determination of drug permeability and binding coefficients in liposomes" 11 : 1314-1325, 2014

53 Sarpietro MG, "Differential scanning calorimetry as a tool to investigate the transfer of anticancer drugs to biomembrane model" 14 : 1053-1060, 2013

54 Csuhai E, "Determination of key parameters for a mechanism-based model to predict Doxorubicin release from actively loaded liposomes" 104 : 1087-1098, 2015

55 Talelli M, "Core-cross linked polymeric micelles with controlled release of covalently entrapped doxorubicin" 31 : 7797-7804, 2010

56 Lee JH, "Controlled drug release from pharmaceutical nanocarriers" 125 : 75-84, 2015

57 Knepp VM, "Controlled drug release from a novel liposomal delivery system. I. Investigation of transdermal potential" 5 : 211-221, 1987

58 Schaefer JJ, "Confocal Raman microscopy probing of temperature-controlled release from individual, optically-trapped phospholipid vesicles" 84 : 9505-9512, 2012

59 Langer R, "Chemical and physical structure of polymers as carriers for controlled release of bioactive agents: a review" 23 : 61-126, 2006

60 O’driscoll CM, "Biopharmaceutical challenges associated with drugs with low aqueous solubility-the potential impact of lipid-based formulations" 60 : 617-624, 2008

61 Yoo HS, "Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA–PEG blockcopolymer" 70 : 63-70, 2001

62 Cauchetier E, "Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristics" 250 : 273-281, 2003

63 Jannin V, "Approaches for the development of solid and semi-solid lipid-based formulations" 60 : 734-746, 2008

64 Craig DQM, "An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscop" 114 : 103-110, 1995

65 Fattal E, "Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release and in vitro antimicrobial activity" 8 : 29-36, 1991

66 Prabaharan M, "Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery" 30 : 5757-5766, 2009

67 Amidon GL, "A theoretical basis for a biopharmaceutic drug classification: the correlation in vitro drug product dissolution and in vivo bioavailability" 12 : 413-420, 1995

68 Ritger PL, "A simple equation for description of solute release II. Fickian and anomalous release from swellable devices" 5 : 37-42, 1987

69 Agrawal S, "A review on novel therapeutics strategies for the enhancement of solubility for hydrophobic drugs through lipid and surfactant based self micro emulsifying drug delivery system: a novel approach" 2 : 143-183, 2012